Identification of high-risk patients in multiple myeloma using a clonal gene signature

被引:0
作者
Li, Jian-Rong
Wang, Christiana
Cheng, Chao
机构
关键词
D O I
10.1158/1538-7445.AM2024-7663
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7663
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Current Review on High-Risk Multiple Myeloma
    Henry S. H. Chan
    Christine I. Chen
    Donna E. Reece
    Current Hematologic Malignancy Reports, 2017, 12 : 96 - 108
  • [32] Identifying the Genomic Profile of Functional High-Risk Multiple Myeloma Patients
    Soekojo, Cinnie Yentia
    Chung, Tae-Hoon
    Furqan, Muhammad Shaheryar
    Chng, Wee-Joo
    BLOOD, 2020, 136
  • [33] Identification of Clonal Igh Gene Rearrangements By High-Throughput Sequencing of Cell Free DNA in Multiple Myeloma Patients
    Gimondi, Silvia
    Cavane, Alessandra
    Vendramin, Antonio
    Giulia, Biancon
    Bermema, Anisa
    Montefusco, Vittorio
    Corradini, Paolo
    Carniti, Cristiana
    BLOOD, 2015, 126 (23)
  • [34] Unifying the Definition of High-Risk in Multiple Myeloma
    Siegel, Ariel
    Boyle, Eileen M.
    Blaney, Patrick
    Wang, Yubao
    Ghamlouch, Hussein
    Choi, Jinyoung
    Caro, Jessica
    Williams, Louis
    Razzo, Beatrice
    Arbini, Arnaldo A.
    Braunstein, Marc
    Kaminetzky, David
    Auclair, Daniel
    Pawlyn, Charlotte
    Cairns, David
    Jackson, Graham
    Walker, Brian
    Bruno, Benedetto
    Morgan, Gareth J.
    Davies, Faith E.
    BLOOD, 2021, 138
  • [35] Evolutionary biology of high-risk multiple myeloma
    Pawlyn, Charlotte
    Morgan, Gareth J.
    NATURE REVIEWS CANCER, 2017, 17 (09) : 543 - 556
  • [36] Understanding high-risk smoldering multiple myeloma
    Kreiniz, Natalia
    Gertz, Morie A.
    LEUKEMIA & LYMPHOMA, 2023, 64 (08) : 1361 - 1372
  • [37] Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics
    Kumar, Shaji
    Fonseca, Rafael
    Ketterling, Rhett P.
    Dispenzieri, Angela
    Lacy, Martha Q.
    Gertz, Morie A.
    Hayman, Suzanne R.
    Buadi, Francis K.
    Dingli, David
    Knudson, Ryan A.
    Greenberg, Alexandra
    Russell, Stephen J.
    Zeldenrust, Steven R.
    Lust, John A.
    Kyle, Robert A.
    Bergsagel, Leif
    Rajkumar, S. Vincent
    BLOOD, 2012, 119 (09) : 2100 - 2105
  • [38] Definition and therapy of high-risk Multiple Myeloma
    Willenbacher, W.
    Willenbacher, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 242 - 242
  • [39] TREATMENT OF HIGH-RISK TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS
    Patriarca, F.
    HAEMATOLOGICA, 2021, 106 (10) : 209 - 211
  • [40] Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients
    Paiva, B.
    Gutierrez, N-C
    Chen, X.
    Vidriales, M-B
    Montalban, M-A
    Rosinol, L.
    Oriol, A.
    Martinez-Lopez, J.
    Mateos, M-V
    Lopez-Corral, L.
    Diaz-Rodriguez, E.
    Perez, J-J
    Fernandez-Redondo, E.
    de Arriba, F.
    Palomera, L.
    Bengoechea, E.
    Terol, M-J
    de Paz, R.
    Martin, A.
    Hernandez, J.
    Orfao, A.
    Lahuerta, J-J
    Blade, J.
    Pandiella, A.
    San Miguel, J-F
    LEUKEMIA, 2012, 26 (08) : 1862 - 1869